Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac

Nobuhiro Suematsu1, Hiroyuki Tsutsui, Jing Wen

  • 1Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Circulation
|March 19, 2003
PubMed
Abstract

Insights

Tumor necrosis factor-alpha (TNF-alpha) triggers reactive oxygen species (ROS) production and mitochondrial DNA (mtDNA) damage in heart cells, contributing to heart failure. Angiotensin II (Ang II) increases ROS but does not damage mtDNA.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor necrosis factor-alpha (TNF-alpha) and angiotensin II (Ang II) are linked to heart failure progression, potentially via reactive oxygen species (ROS).
  • The precise mechanisms of agonist-induced ROS production and its impact on cardiac myocytes, particularly mitochondrial DNA (mtDNA), remain unclear.
  • Previous studies indicated a correlation between elevated ROS, mtDNA damage, and dysfunction in failing hearts.

Purpose of the Study:

  • To investigate if direct exposure of cardiac myocytes to TNF-alpha and Ang II in vitro induces mtDNA damage through ROS production.
  • To elucidate the signaling pathways involved in TNF-alpha-mediated ROS production and subsequent mtDNA damage.

Main Methods:

  • Cultured neonatal rat ventricular myocytes were exposed to TNF-alpha and Ang II.
  • Reactive oxygen species (ROS) production was assessed using 2',7'-dichlorofluorescin diacetate fluorescence.
  • Mitochondrial DNA (mtDNA) copy number was quantified by Southern blot analysis.
  • The role of the sphingomyelin-ceramide pathway was examined using D609 and C2-ceramide.

Main Results:

  • TNF-alpha significantly increased ROS production and decreased mtDNA copy number in myocytes.
  • The TNF-alpha-induced decrease in mtDNA copy number was associated with reduced complex III activity and was prevented by alpha-tocopherol.
  • Hydrogen peroxide (H2O2) exposure mimicked the mtDNA copy number reduction.
  • Ang II increased ROS but did not affect mtDNA copy number.
  • The sphingomyelinase inhibitor D609 and C2-ceramide blocked TNF-alpha-mediated ROS production and mtDNA damage, implicating the sphingomyelin-ceramide pathway.

Conclusions:

  • TNF-alpha induces cardiac myocyte ROS production and mtDNA damage via the sphingomyelin-ceramide pathway.
  • This link between TNF-alpha, ROS, and mtDNA damage is a potential contributor to myocardial remodeling and heart failure.
  • Angiotensin II's role in mtDNA damage appears distinct from TNF-alpha despite similar ROS induction.

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations01:51

Vaccinations

Overview
51.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K